🇺🇸 FDA
Patent

US 8148323

Method of treating or inhibiting inflammation by multi-domain amphipathic helical peptides

granted A61KA61K38/00A61P

Quick answer

US patent 8148323 (Method of treating or inhibiting inflammation by multi-domain amphipathic helical peptides) held by The United States of America as Represented by the Secretary of the Department of Health and Human Services expires Mon Mar 29 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America as Represented by the Secretary of the Department of Health and Human Services
Grant date
Tue Apr 03 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 29 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
8
CPC classes
A61K, A61K38/00, A61P, A61P29/00, A61P3/00